Alnylam Pharmaceuticals
ALNY
#801
Rank
NZ$54.41 B
Marketcap
NZ$406.69
Share price
1.51%
Change (1 day)
-46.26%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company